Identification of sarcomeric variants in probands with a clinical diagnosis of arrhythmogenic right ventricular cardiomyopathy (ARVC)
- PMID: 29709087
- PMCID: PMC6055742
- DOI: 10.1111/jce.13621
Identification of sarcomeric variants in probands with a clinical diagnosis of arrhythmogenic right ventricular cardiomyopathy (ARVC)
Abstract
Aims: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited cardiomyopathy characterized by ventricular arrhythmias and sudden death. Currently 60% of patients meeting Task Force Criteria (TFC) have an identifiable mutation in one of the desmosomal genes. As much overlap is described between other cardiomyopathies and ARVC, we examined the prevalence of rare, possibly pathogenic sarcomere variants in the ARVC population.
Methods: One hundred and thirty-seven (137) individuals meeting 2010 TFC for a diagnosis of ARVC, negative for pathogenic desmosomal variants, TMEM43, SCN5A, and PLN were screened for variants in the sarcomere genes (ACTC1, MYBPC3, MYH7, MYL2, MYL3, TNNC1, TNNI3, TNNT2, and TPM1) through either clinical or research genetic testing.
Results: Six probands (6/137, 4%) were found to carry rare variants in the sarcomere genes. These variants have low prevalence in controls, are predicted damaging by Polyphen-2, and some of the variants are known pathogenic hypertrophic cardiomyopathy mutations. Sarcomere variant carriers had a phenotype that did not differ significantly from desmosomal mutation carriers. As most of these probands were the only affected individuals in their families, however, segregation data are noninformative.
Conclusion: These data show variants in the sarcomere can be identified in individuals with an ARVC phenotype. Although rare and predicted damaging, proven functional and segregational evidence that these variants can cause ARVC is lacking. Therefore, caution is warranted in interpreting these variants when identified on large next-generation sequencing panels for cardiomyopathies.
Keywords: ARVC; cardiomyopathy; genetics; sarcomere; whole-exome sequencing.
© 2018 The Authors. Journal of Cardiovascular Electrophysiology published by Wiley Periodicals, Inc.
Figures
Similar articles
-
Prevalence and significance of rare RYR2 variants in arrhythmogenic right ventricular cardiomyopathy/dysplasia: results of a systematic screening.Heart Rhythm. 2014 Nov;11(11):1999-2009. doi: 10.1016/j.hrthm.2014.07.020. Epub 2014 Jul 17. Heart Rhythm. 2014. PMID: 25041964
-
Arrhythmogenic Right Ventricular Cardiomyopathy-Associated Desmosomal Variants Are Rarely De Novo.Circ Genom Precis Med. 2019 Aug;12(8):e002467. doi: 10.1161/CIRCGEN.119.002467. Epub 2019 Aug 6. Circ Genom Precis Med. 2019. PMID: 31386562
-
LMNA cardiomyopathy detected in Japanese arrhythmogenic right ventricular cardiomyopathy cohort.J Cardiol. 2016 Oct;68(4):346-51. doi: 10.1016/j.jjcc.2015.10.013. Epub 2015 Nov 25. J Cardiol. 2016. PMID: 26620845
-
Arrhythmogenic right ventricular cardiomyopathy, clinical manifestations, and diagnosis.Europace. 2016 Jul;18(7):965-72. doi: 10.1093/europace/euv340. Epub 2015 Oct 25. Europace. 2016. PMID: 26498164 Review.
-
[Mutations in genes for sarcomeric proteins].Nihon Rinsho. 2000 Jan;58(1):117-22. Nihon Rinsho. 2000. PMID: 10885298 Review. Japanese.
Cited by
-
Pathophysiology of dilated cardiomyopathy: from mechanisms to precision medicine.Nat Rev Cardiol. 2025 Mar;22(3):183-198. doi: 10.1038/s41569-024-01074-2. Epub 2024 Oct 11. Nat Rev Cardiol. 2025. PMID: 39394525 Free PMC article. Review.
-
Variants in MHY7 Gene Cause Arrhythmogenic Cardiomyopathy.Genes (Basel). 2021 May 22;12(6):793. doi: 10.3390/genes12060793. Genes (Basel). 2021. PMID: 34067482 Free PMC article.
-
A Heterozygous Phospholamban Variant (p.R14del) Leads to Left Ventricular Involvement and Heart Failure Phenotypes in Arrhythmogenic Right Ventricular Cardiomyopathy.Phenomics. 2024 Jan 29;4(1):13-23. doi: 10.1007/s43657-023-00126-w. eCollection 2024 Feb. Phenomics. 2024. PMID: 38605909 Free PMC article.
-
Case report: Severe arrhythmogenic cardiomyopathy in a young girl with compound heterozygous DSG2 and MYBPC3 variants with a 6-year follow-up.Front Genet. 2025 Mar 6;16:1545561. doi: 10.3389/fgene.2025.1545561. eCollection 2025. Front Genet. 2025. PMID: 40115818 Free PMC article.
-
International Evidence Based Reappraisal of Genes Associated With Arrhythmogenic Right Ventricular Cardiomyopathy Using the Clinical Genome Resource Framework.Circ Genom Precis Med. 2021 Jun;14(3):e003273. doi: 10.1161/CIRCGEN.120.003273. Epub 2021 Apr 8. Circ Genom Precis Med. 2021. PMID: 33831308 Free PMC article. Clinical Trial.
References
-
- Dalal D, Nasir K, Bomma C, et al. Arrhythmogenic right ventricular dysplasia: A United States experience. Circulation. 2005;112:3823–3832. - PubMed
-
- Bhonsale A, Groeneweg JA, James CA, et al. Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia/cardiomyopathy‐associated mutation carriers. Eur Heart J. 2015;36:847–855. - PubMed
-
- Groeneweg JA, Bhonsale A, James CA, et al. Clinical presentation, long‐term follow‐up, presentation, long‐term follow‐up, and outcomes of 1001 arrhythmogenic right ventricular dysplasia/cardiomyopathy patients and family members. Circ Cardiovasc Genet. 2015;8:437–446. - PubMed
-
- Mayosi BM, Fish M, Shaboodien G, et al. Identification of Cadherin 2 (CDH2) mutations in arrhythmogenic right ventricular cardiomyopathy. Circ Cardiovasc Genet. 2017;10. - PubMed
-
- van Hengel J CaloreM, Bauce B, et al. Mutations in the area composita protein αT‐catenin are associated with arrhythmogenic right ventricular cardiomyopathy. Eur Heart J. 2013;34:201–210. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous